Georgia is a dedicated Trainee Patent Attorney in Marks & Clerk’s Life Sciences team, based in Cambridge. Georgia graduated with an Integrated Master’s in Biosciences from Durham University in 2021, specializing in biomedical studies.

Georgia assists in drafting and prosecuting international and national patent applications, with particular expertise in European patents and other commercially significant jurisdictions, including the US, China, Japan, Australia, and Canada. She confidently supports the strategic development of IP portfolios for a diverse client base, ranging from innovative start-ups and SMEs to leading research institutions and global corporations. Georgia primarily works with clients in the agritech and pharmaceutical industries, providing tailored intellectual property strategies to support innovation and commercial growth.

In the agritech space, Georgia works across a broad spectrum of cutting-edge technologies, including chimeric plant proteins, genetically modified crops showing enhanced performance and resistance, and plant transformation systems for example, plant-based Omega-3 production. 

Georgia is currently completing a secondment with a global pharmaceutical company headquartered in Cambridge. Georgia is assisting with the management and development of a complex global portfolio covering numerous on market products including anti-fungal treatments, stimulants for ADD and ADHD, a first-in-class chemotherapeutic drug, and opioid antagonists.